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EXPRESSION  OF A  SINGLE  MAJOR  HISTOCOMPATIBILITY 
COMPLEX  LOCUS  CONTROLS  THE  IMMUNE 
RESPONSE  TO POLY-L-(TYROSINE, 
GLUTAMIC  ACID)-POLY-DL-ALANINE--POLY-L-LYSINE* 
BY  BEVERLY  D.  DEAK,  DANIEL  MERUELO,*  AND  HUGH  O.  McDEVITT 
(From the Division of lmrnunology,  Department of Medicine, Stanford University School of 
Medicine, Stanford, California 94305) 
Genetic control of the immune response linked to the major histocompatibility 
(H-2)  complex  in  the  mouse  has  been  described  for  synthetic  polypeptide 
antigens  and  for  low  doses  of  native  proteins.  The  phenomenon  is  well 
documented (1, 2). Extensive screening of intra-H-2 crossover-derived recombi- 
nant  strains  has  localized H-2-1inked  immune  response  (Ir)  genes  to  the I- 
immune  response region of the H-2  complex (3).  For most antigens, Ir  genes 
are  autosomal,  dominant,  and  they segregate  as  single  loci.  It is  not  known 
whether  these  crossover-defined  loci  represent  single  genes  with  multiple 
alleles or clusters of tightly linked genes (4). 
In 1972, Stimpfling and Durham (5) postulated that two interacting loci within the H- 
2 complex were required for the response to the alloantigen, H-2.2 (6), and, in 1975, Doff 
et al.  (7) observed a  responder phenotype in a  recombinant derived from two strains 
which were nonresponders to the synthetic linear terpolymer, L-glutamic acid, L-lysine, 
L-phenylalanine  (GLPhe).  Analysis of additional  recombinants  and  complementation 
tests with F1 hybrids clearly demonstrated that genes in two intra-l-region loci controlled 
the immune response to GLPhe. Subsequently, requirements for genes mapping in two 
intra-/-region loci were reported for porcine LDHB (8), the alloantigen Thy-l.1 (9), and 
for the synthetic terpolymers L-glutamic acid, L-lysine, L-tyrosine and L-glutamic acid, 
L-lysine, L-leucine (6, 10). 
Demonstration  that  responses  to  both  synthetic  polypeptide  and  native  protein 
antigens can be controlled by genes in two distinct/-region loci prompted speculation 
that the phenotypic expression of two/-region genes is a  general phenomenon which 
may provide the key for understanding the mechanism oflr gene function and cellular 
collaboration in the immune response.  Benacerraf and Doff (10) have shown that Ir 
gene complementation is often more effective in the c/s than in the trans configuration. 
This concept is further supported by the data reported for GLPhe (10-12) which indicate 
that  both  of the  complementing genes  must  be expressed in  each of the  cell types 
participating in the interaction. Failure to detect complementation for the majority of 
antigens under H-2-1inked Ir-gene control might be attributed to the limited number of 
available intra-I-region recombinant strains. 
Munro and Taussig (13) reported trans complementation for the primary IgM response 
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to the synthetic random polypeptide poly-L-(tyrosine, glutamic  acid)-poly-DL-alanine-- 
poly-L-lysine, abbreviated .  (T, G)-A--L, both in vivo in (B10.M  × B10.BR)F1 (H-2 s × H- 
2 k) hybrids, and in a thymus-derived helper factor-bone marrow reconstitution system 
in which B10.BR factor complemented B10.M bone marrow. The results of the reconsti- 
tution experiments suggested that the complementing genes are expressed in distinct 
lymphocyte populations.  The  complemented response was  equivalent  to  that  of the 
responder phenotype (H-2 b) in both systems. 
Complementation for the response to (T, G)-A--L has also been reported by Swartz et 
al.  (12). Using an antigen-induced T- (thymus-derived) lymphocyte proliferation assay, 
intermediate levels of stimulation between low- and high-responder phenotypes were 
obtained in the  (B10.M  ×  B10.BR)F~ hybrid. The T-lymphocyte proliferation assay is 
reported to be B- (bone marrow-derived) lymphocyte independent (12). These findings 
suggest, therefore, that coexpression of both genes must occur in another cell population; 
presumably in T cells and/or macrophages. 
Extensive screening in our laboratory of the IgG secondary response to  (T, 
G)-A--L  of  intra-H-2  crossover-derived  recombinant  strains  (3),  and  of  F~ 
hybrids  derived from  low-responder  parents  (B.  Deak  and  H.  O.  McDevitt, 
unpublished observations) did not suggest a  requirement for two separable I- 
region  genes.  However,  given  the  limited  numbers  of recombinant  strains 
available for analysis and the demonstrated two-gene requirement in several 
systems, additional F~ hybrids were studied for both primary and secondary in 
vivo response to (T, G)-A--L. 
Materials  and  Methods 
A minimum  of six mice per group were primed  intraperitoneally with  10  /~g (T, G)-A--L 
(batches 52 or 1383) in complete Freund's adjuvant. These mice were bled on days 14 and]or 21 for 
the primary  response,  boosted  intraperitoneally  on day 21 with 10 ~g antigen  in phosphate- 
buffered  saline,  and  bled  again  on  day 28  for  the  secondary  response.  Each  experiment  included  a 
group  of  animals  possessing  the  H-2  b  (high  responder)  haplotype. 
Levels  of  IgM and IgG antibodies  were determined  by an assay  for antibody-forming  cells 
(plaque  assay)  (14),  by the binding  of  serum antibodies  to antigens  in solution  (modified  Farr 
assay) (3),  and by the binding  of serum antibodies  to antigens  fixed  in the solid  phase in 
microtiter  plates  (plate  assay)  (15). 
Results 
The results of  immunizing multiple combinations of  FI hybrids derived from 
crosses between low-responder haplotypes are shown in Fig. 1, in which all FI 
crosses are between  H-2  congenic partners,  and in Fig. 2, in which  all FI 
crosses  are  noncongenic.  None  of the  FI  hybrids  produced  a  primary  or 
secondary response greater than that of  the parental strains, including (B10.  M 
× B10.BR)F~, which was reported by Munro and Taussig (13)  and Swartz et al. 
(12)  to complement to produce a high response. 
The secondary response of strain A.CA  (Fig. 2) is intermediate, and is most 
likely the result of the influence of non-H-2  genes on the magnitude  of the 
response. A  comparison of the high-responder allele,  H-2  b, on the B10 and A 
backgrounds  (16) clearly demonstrates  this effect.  FI hybrids between  A.CA 
and low-responder haplotypes respond to a lesser degree than does A.CA  (Fig. 
2), providing additional evidence for lack of  complementation. 
To resolve this discrepancy, B10.BR, B10.M, and (B10.M × B10.BR)F~ mice, 
kindly supplied by Dr. Alan Munro  (Cambridge University, Cambridge, Eng- z 
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Fro. 1.  Primary and secondary response to 10 pg (T, G)-A--L 52 in congenic F~ hybrids, 
determined by binding of  pooled serum antibodies to 1=SI-labeled  (T, G)-A--L, in a modified 
Farr assay. The sera were assayed at a dilution of 1:50  for the primary (1  °) response and 
1:250 for the secondary  (2  °) response.  The shaded areas represent 2-mercaptoethanol- 
resistant antibodies, which are assumed to be IgG. IgM antibodies are total  antibodies 
minus 2-rnercaptoethanol-resistant antibodies. 
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Fro.  2.  Primary  and  secondary  response  to  10  ~g  (T,  G)-A--L  1383  in  noncongenic  Ft 
hybrids by binding of  pooled serum antibodies to ~2Sl-laboled  (T, G)-A--L in a modified Farr 
assay. The sera were assayed at a dilution of 1:50  for the primary (1  °) response and 1:250 
for the secondary (2  °) response. The shaded areas represent 2-mercapthoethanol-resistant 
antibodies, which are assumed to  be IgG. IgM antibodies are total  antibodies minus the 2- 
mercaptoethanol-resistant antibodies. 
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FIG.  3.  Comparison of the primary and secondary antibody-forming cell response to  10 
~g.  (T, G)-A--L 1383 in Stanford (Stan) lines and Cambridge (CAM) lines. The direct (-) 
number  of plaque-forming cells  (PFC)  was  determined  with  poly-L-(tyrosine,  glutamic 
acid)-poly-DL-proline-poly-L-lysine-tagged  sheep  erythrocytes.  The  indirect  (---) PFC 
number was determined with (T, G)-A--L-tagged  sheep erythrocytes. 
land), were used in concert with B10, B10.BR, B10.M, and (B10.M ×  B10.BR)F1 
mice bred in our facilities at Stanford.  The mice were grouped so that parallel 
determinations of the antibody response by plaque assay, modified Farr assay, 
and plate assay could be determined on days 0,  14,  21,  and 28.  The results of 
these determinants by three independent methods were concordant. The results 
for the plaque assay are presented in Fig. 3. The results for the modified Farr 
assay and the plate assay are not shown. None of the assay methods detected 
complementation in the F1 for high  responsiveness in the primary or the sec- 
ondary response. 
A  similar  study  using  the  related  random  synthetic  polypeptide  antigen 
poly-L-(histidine,  glutamic adic)-poly-DL-alanine--poly-L-lysine produced analo- 
gous results (data not shown). 
Discussion 
The differences observed between phenotypes in the  (T, G)-A--L system are 
quantitative,  and it is the level of responsiveness that is under genetic control. 
Variations  in response patterns  to different preparations  of (T,  G)-A--L are 
not  uncommon  in  the  primary  response  (17),  and,  for  some  but  not  all 
preparations,  high and low responders are equivalent (2). Variations in second- 
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observed (B.  Deak and H. O.  McDevitt, unpublished observations). 
This quantitative difference is most obvious in the secondary IgG response. 
Clearly, there is significant variation in the level of response among strains of 
low-responder phenotype, particularly for the IgM primary. Amplification by 
non-H-2 genes of the IgG secondary response has been observed for some low- 
responder haplotypes. 
While  two-gene  complementation  in  the  genetic  control  of the  immune 
response  to other antigens certainly exists  (7), we cannot confirm a  similar 
complementation in the immune response to (T, G)-A--L.  These results clearly 
show that there is no in vivo complementation in F1 hybrids derived from low- 
responder parents for the IgM primary or the IgG secondary immune response. 
Reported in vivo complementation (13) in the primary immune response to 
(T,  G)-A--L in  (B10.M  x  B10.BR)F1  hybrids has been cited as  an important 
confirmation of earlier results  (18, 19) which indicated that genes in the I-A 
subregion controlled the production of a T-cell factor and a B'cell acceptor, both 
of which were specific for (T, G)-A--L and were required for the production of a 
high response. Despite repeated attempts, we have found these results difficult 
to reproduce (D.  Meruelo and H. O.  McDevitt, unpublished observations). 
Our failure to confirm the reported in vivo complementation in the (B10.M x 
B10.BR)F~ hybrid in repeated experiments employing several different antibody 
assays,  or to  demonstrate complementation in  multiple combinations of low 
responder F~ hybrids, indicates that the proposed "factor-acceptor" model lacks 
confirmation by an independent experimental approach. In the absence of such 
confirmation, we feel this model for Ir gene expression cannot be considered to 
be established. 
The authors  wish to  thank Dr. Jack H. Stimpfling for  his  generous gift  of  mice. 
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